IDRC Digital Library

Incentivising african pharmaceutical manufacturing : policies for sustaining the take-off

Show simple item record Bolo, Maurice
dc.contributor.editor Islet Investments, Nairobi 2020-03-30T10:53:58Z 2020-03-30T10:53:58Z 2016-11
dc.description.abstract This brief draws on country studies from around the world to illustrate how the pharmaceutical industry can be further developed in African countries. Building the knowledge base and strengthening linkages between knowledge producers and users is critical in shaping the direction of development. The role of public policy in supporting the continued growth of the African pharmaceutical manufacturing sector is emphasized. Thirty-seven countries in sub-Saharan Africa are engaged in pharmaceutical manufacturing supplying about 30% of the local market. South Africa, Kenya, Nigeria, and Ghana have substantial pharmaceutical manufacturing plants. en
dc.format.mimetype application/pdf
dc.language.iso en
dc.publisher The Scinnovent Centre en
dc.relation.ispartof Technical briefing note no. 1 en
dc.subject PHARMACOLOGY en
dc.subject ACCESS TO MEDICINE en
dc.subject STANDARDS en
dc.subject LICENSING en
dc.subject REGULATION en
dc.subject KENYA en
dc.subject SOUTH OF SAHARA en
dc.title Incentivising african pharmaceutical manufacturing : policies for sustaining the take-off en
dc.type Policy Brief en
idrc.project.number 107975
idrc.project.componentnumber 107975001
idrc.project.title Toward a Regional Research Agenda on Pharmaceutical Manufacturing and Access to Medicines in Sub-Saharan Africa en
idrc.copyright.holder © 2016 The Scinnovent Centre
idrc.copyright.oapermissionsource CC BY-NC-SA 4.0 International en
idrc.dspace.access Open Access en
idrc.rims.adhocgroup IDRC SUPPORTED en
idrc.recordsserver.bcsnumber IC36-1643402171-166743

Files in this item

This item appears in the following Collection(s)

Show simple item record